Worth reading
55In focus
Scored from 2 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
590000
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
13th Stock Acquisition Rights issued through a third-party allotment (with an exercise price adjustment clause)
発行・処分する株式数590,000Shares
590,000 shares delivered during the month under review
発行済株式総数
Exercise ratio subject to exercise restrictions: 1.1% (590,000 shares delivered across all series / 53,641,000 listed shares outstanding as of the payment date for the issuance)
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
Terms of the stock acquisition rights
Exercise price
Exercise prices in July 2026 were ¥70, ¥77, ¥82, ¥75, ¥72 and ¥70. Details of the adjustment clause and the floor price: not disclosed
Number of Stock Acquisition Rights
Total issued: 70,000 (exercise ratio of 8.43% of the total issued as of the exercise of 5,900); unexercised at the end of the month preceding the month under review: 28,026; unexercised at the end of the month under review: 22,126
Procedures under the Corporate Code of Conduct
The disclosure describes compliance with exercise restrictions under Article 434 of the Tokyo Stock Exchange's Securities Listing Regulations and the Japan Securities Dealers Association's Rules Concerning the Handling of Third-Party Allotments and Other Transactions.
Most recent equity financing
Timing 13 January 2026 / Type Issuance of the 13th Stock Acquisition Rights (with Exercise Price Adjustment Clause) through a Third-Party Allotment / Amount Not disclosed
| Item | Details |
|---|---|
| Type of issuance or disposal | 13th Stock Acquisition Rights issued through a third-party allotment (with an exercise price adjustment clause) |
| Number of shares to be issued or disposed of | 590,000 shares delivered during the month under review |
| Dilution Rate | Exercise ratio subject to exercise restrictions: 1.1% (590,000 shares delivered across all series / 53,641,000 listed shares outstanding as of the payment date for the issuance) |
| Total number of issued shares | 57,838,400 shares (as of the end of the month preceding the month under review) → Not disclosed |
| Exercise price | Exercise prices in July 2026 were ¥70, ¥77, ¥82, ¥75, ¥72 and ¥70. Details of the adjustment clause and the floor price: not disclosed |
| Number of Stock Acquisition Rights | Total issued: 70,000 (exercise ratio of 8.43% of the total issued as of the exercise of 5,900); unexercised at the end of the month preceding the month under review: 28,026; unexercised at the end of the month under review: 22,126 |
| Procedures under the Corporate Code of Conduct | The disclosure describes compliance with exercise restrictions under Article 434 of the Tokyo Stock Exchange's Securities Listing Regulations and the Japan Securities Dealers Association's Rules Concerning the Handling of Third-Party Allotments and Other Transactions. |
| Most recent equity financing | Timing 13 January 2026 / Type Issuance of the 13th Stock Acquisition Rights (with Exercise Price Adjustment Clause) through a Third-Party Allotment / Amount Not disclosed |
Items this document does not state (20)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allotteeIntended allottee's holding policyBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To report the monthly exercise status in July 2026 of the 13th Series of Stock Acquisition Rights issued on 13 January 2026.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.